US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma The Premise supported by this stance on the part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback